- Breast screening detection plus engagement
- Targets radiology needs rather than a generic suite
- Scales to organization-wide healthcare rollouts
Whiterabbit.ai
Breast cancer screening detection AI
SF7.2
SF Score editorial score across features, ease, and value, based on public reviews and product research. Learn more →
Support reporting language consistencyBreast imaging and screening programs
Support reporting language consistencyBreast imaging and screening programs
Best for
Breast imaging and screening programs
Pricing
Custom
SoftFinders Score
7.2 / 10
Overview
What is Whiterabbit.ai?
Whiterabbit.ai is an AI company focused on breast cancer screening that supports mammography reading and patient screening engagement. The product is positioned around imaging triage, finding prioritization, and radiologist productivity rather than autonomous interpretation, and regulatory clearance scope and validation depth vary by clinical indication. Buyers should confirm clearance details, integration with PACS and worklist tools, and impact metrics for the specific reading workflow being supported.
Whiterabbit.ai works best for breast imaging and screening programs, and its edge is breast screening detection plus engagement. The honest trade-off here: scope focused on breast screening only. Pricing is sales-led and scoped per buyer rather than posted publicly. Run a small pilot to confirm fit before committing to a wider rollout.
KEY FEATURES
What you get out of the box
Population Screening
Supports screening across imaging populations
Performance Metrics
Reports performance metrics for imaging programs
Finding Triage
Flags suspected critical findings for prioritization
Worklist Integration
Integrates flagged studies into radiologist worklist
Multi Modality
Supports CT, MRI, X-ray, and related modalities
Care Coordination
Routes alerts to relevant care team members
USE CASES
Where teams put it to work
Support reporting language consistency
Triage screening exams at scale
Reduce missed findings on busy lists
Bridge imaging and downstream pathways
Track outcomes from flagged studies
Standardize follow-up recommendations
Editorial Take
What we like, and what to verify
- Scope focused on breast screening only
- Radiologist confirmation required on every study
- Pricing is sales-led and needs scoping upfront
Screenshots
A look inside
Alternatives
Tools to consider next
Gleamer SF 8
Why consider it
Broad X-ray AI suite for radiology
Qure.ai SF 8.1
Why consider it
Global chest, CT, and stroke imaging AI
RapidAI SF 8
Why consider it
Stroke and vascular imaging triage platform
Subtle Medical SF 7.7
Why consider it
AI image enhancement for MRI and PET
Imagen Technologies SF 7.5
Why consider it
AI-supported radiology reads and workflow
Riverain Technologies SF 7.4
Why consider it
Chest and lung X-ray detection AI
FAQ